SUBSCRIBE
SUBSCRIBE

Rezolute, Inc.

NEWS
Woman With Pipette And Test Tubes
Drug Development
Clinical Catch-Up: Moderna COVID-19 Vaccine for Kids and Much More
Although it was relatively quiet in COVID-19-related clinical trials, there was plenty of other clinical trial news. Here’s a look.
March 25, 2022
 · 
10 min read
 · 
Mark Terry
Business
BioSpace Movers & Shakers, March 12
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
March 11, 2021
 · 
7 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Press Releases
Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4) - December 5, 2024
December 6, 2024
 · 
3 min read
Press Releases
FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
December 4, 2024
 · 
5 min read
Press Releases
Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update
November 8, 2024
 · 
6 min read
Press Releases
Rezolute to Participate in Upcoming November 2024 Investor Conferences
November 6, 2024
 · 
1 min read
Business
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
September 19, 2024
 · 
8 min read
Press Releases
Rezolute to Participate in Upcoming Investor Conferences
August 27, 2024
 · 
1 min read
Press Releases
Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
August 5, 2024
 · 
5 min read
Press Releases
Rezolute to Participate in the BTIG Virtual Biotechnology Conference
July 31, 2024
 · 
1 min read
Pharm Country
Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
June 27, 2024
 · 
4 min read
Pharm Country
Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds
June 24, 2024
 · 
4 min read
Load More